Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

IPS Features Q&A With Executive Director of Global HIV Vaccine Enterprise

From Henry J. Kaiser Family Foundation

April 27, 2010

In a Q&A with Inter Press Service, Executive Director of the Global HIV Vaccine Enterprise Alan Bernstein reflects on the recent progress made in HIV vaccine development and the need for partnerships between academia, industry, public and private funders to speed vaccine development. Bernstein also comments on how the global economy has impacted HIV vaccine research (Kharsany, 4/26).

Back to other news for April 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More News and Analysis on Vaccines for HIV Prevention

Tools
 

Advertisement